Richard Campbell

Richard Campbell serves as Vice President of Clinical Operations at Zentalis Pharmaceuticals since August 2025. Previously, Richard held the position of Vice President and Head of Clinical Operations at Mural Oncology from September 2023 to July 2025, where leadership focused on the delivery of oncology clinical trials and the establishment of a top-tier Clinical Operations team. Prior experience includes a tenure at Bristol-Myers Squibb as Vice President for Global Clinical Trial Planning & Alliance Management, contributing to the approval of nine new FDA drugs in three years. Involvement with TransCelerate BioPharma Inc. covered oversight of collaborative R&D projects aimed at enhancing clinical trial efficiency. Richard’s career began at Novo Nordisk, progressing from Senior Director of Clinical Trial Business Management to other roles focused on information management and medical information. Educational background includes a Master in Medical Business Strategy from CBS Executive Fonden and multiple degrees in English and Library & Information Science.